BPA for balversa
Ended Awarded Last action
- Contract number
- 36E79720A0015
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 6 $193,303 obligated
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Combined order value
- $193,303 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 5% used
- $3,734,928.25
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The U.S. Department of Veterans Affairs (VA) awarded a $3.7 million Blanket Purchase Agreement (BPA) to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., a large pharmaceutical manufacturer. The BPA allows VA medical facilities to place firm fixed price call orders for the oncology medications BALVERSA (erdafitinib) and Belzutifan (WELIREG) through July 2024. This streamlined procurement vehicle supports the VA's Veterans Health Administration (VHA) in maintaining a steady supply of critical cancer treatments to serve veteran patients nationwide.
Janssen Biotech also holds a $3.1 billion multiple-award Federal Supply Schedule (FSS-61-IB) contract with the VA for a broad range of pharmaceutical products. The BPA call orders and FSS contract enable various VA Veterans Integrated Service Networks (VISNs) to efficiently order and receive these oncology drugs on an as-needed basis, often for emergency patient care requirements. These contract awards do not include any set-aside designations, reflecting Janssen Biotech's status as a large, for-profit manufacturer.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Show all 13
Quick answers
Who was awarded contract 36E79720A0015?
36E79720A0015 was awarded to Janssen Biotech Inc. by National Acquisition Center (Headquarters) on August 1, 2020.
How much is contract 36E79720A0015 worth?
Orders under 36E79720A0015 have obligated $193,303. 36E79720A0015's own ceiling is $3,734,928.
How many orders have been placed under contract 36E79720A0015?
6 orders have been placed under 36E79720A0015, the latest on May 26, 2022.
Who can order from contract 36E79720A0015?
36E79720A0015 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79720A0015 under another contract?
Yes. 36E79720A0015 is a blanket purchase agreement under 36F79719D0217, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79720A0015 competed?
The extent of competition for 36E79720A0015 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV